IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases

Rajesh Krishna; Anneliene H. Jonker; Thomas Morel; Ken Sakushima; Anna M. G. Pasmooij; Daniel O'Connor

doi:10.1038/d41573-024-00196-z

IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases

Rajesh Krishna, Anneliene H. Jonker, Thomas Morel, Ken Sakushima, Anna M. G. Pasmooij, Daniel O'Connor^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential.

Original language	English
Pages (from-to)	233-234
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	24
Issue number	4
Early online date	16 Dec 2024
DOIs	https://doi.org/10.1038/d41573-024-00196-z
Publication status	Published - Apr 2025

Bibliographical note

Publisher Copyright:
© Springer Nature Limited 2024.

Access to Document

10.1038/d41573-024-00196-z

Cite this

@article{630b10e4b61848a28883e790a10a2706,

title = "IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases",

abstract = "New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential.",

author = "Rajesh Krishna and Jonker, {Anneliene H.} and Thomas Morel and Ken Sakushima and Pasmooij, {Anna M. G.} and Daniel O'Connor",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2025",

month = apr,

doi = "10.1038/d41573-024-00196-z",

language = "English",

volume = "24",

pages = "233--234",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "4",

}

TY - JOUR

T1 - IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases

AU - Krishna, Rajesh

AU - Jonker, Anneliene H.

AU - Morel, Thomas

AU - Sakushima, Ken

AU - Pasmooij, Anna M. G.

AU - O'Connor, Daniel

PY - 2025/4

Y1 - 2025/4

N2 - New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential.

AB - New approaches are needed to streamline clinical trials of drugs for patients with rare diseases. Digital biomarkers offer one such approach, but several challenges must be addressed to realize their potential.

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=d7dz6a2i7wiom976oc9ff2iqvdhv8k5x&SrcAuth=WosAPI&KeyUT=WOS:001459329300007&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1038/d41573-024-00196-z

DO - 10.1038/d41573-024-00196-z

M3 - Editorial

C2 - 39681697

SN - 1474-1776

VL - 24

SP - 233

EP - 234

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 4

ER -

IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases

Abstract

Bibliographical note

Access to Document

Other files and links

Embargoed Document

Fingerprint

Cite this